Epizyme (EPZM) Reports Q2 Loss of $0.42

Epizyme (NASDAQ: EPZM) reported Q2 EPS of ($0.42), versus ($0.48) reported last year. Revenue for the quarter came in at $12 million, versus $10 million reported last year.

GUIDANCE:

Epizyme has extended its cash runway guidance based on changes that are being made to its planned operating expenditures. The company now expects that its existing cash, cash equivalents and marketable securities will be sufficient to fund its planned operations into the fourth quarter of 2019.

For earnings history and earnings-related data on Epizyme (EPZM) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery